Tower Research Capital LLC (TRC) - IMMIX BIOPHARMA INC ownership

IMMIX BIOPHARMA INC's ticker is and the CUSIP is 45258H106. A total of 19 filers reported holding IMMIX BIOPHARMA INC in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of IMMIX BIOPHARMA INC
ValueSharesWeighting
Q2 2023$323
+2591.7%
120
-98.1%
0.00%
Q1 2023$12
+140.0%
6,375
+170.6%
0.00%
Q4 2022$52,356
+842.4%
0.00%
Q3 2022$02500.00%
Other shareholders
IMMIX BIOPHARMA INC shareholders Q2 2023
NameSharesValueWeighting ↓
Lynwood Capital Management Inc. 200,250$538,6730.68%
Imprint Wealth LLC 22,280$42,3320.03%
Moss Adams Wealth Advisors LLC 20,000$53,8000.02%
Koshinski Asset Management, Inc. 51,001$137,1930.02%
UMB Bank, n.a. 72,639$195,3990.00%
InterOcean Capital Group, LLC 15,900$42,7710.00%
WELLS FARGO & COMPANY/MN 42$1130.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GEODE CAPITAL MANAGEMENT, LLC 60,326$162,2760.00%
STATE STREET CORP 42,960$115,5620.00%
View complete list of IMMIX BIOPHARMA INC shareholders